Acute promyelocytic leukemia as a cause of intracoronary drug-eluting-stent thrombosis.

Abstract

Stent thrombosis is a potentially lethal complication of percutaneous coronary intervention. We describe the case of a 51-year-old man who presented with acute anterior ST-segment-elevation myocardial infarction and underwent successful percutaneous transluminal coronary angioplasty and placement of 3 drug-eluting stents in the left anterior descending coronary artery. Despite receiving dual antiplatelet therapy, the patient presented a week later with a non-ST-segment-elevation myocardial infarction and was found to have nonocclusive thrombosis of the left anterior descending coronary artery stents and his ostial left main and left circumflex coronary arteries. Subsequently, bone marrow biopsy analysis indicated that the patient had acute myelogenous leukemia, which we believe was the underlying cause of his prothrombotic state and stent thrombosis.

• Authors: Zaven Sargsyan, Christopher Higgins, Sanda Alexandrescu, David A Ott, Surendra K Jain
• Journal: Texas Heart Institute journal (Tex Heart Inst J) Vol. 39 Issue 3 Pg. 416-9 ( 2012) ISSN: 1526-6702 [Electronic] United States
• PMID: 22719158 (Publication Type: Case Reports, Journal Article)

Chemical References

• Platelet Aggregation Inhibitors

Topics

• Angioplasty, Balloon, Coronary (adverse effects, instrumentation)
• Anterior Wall Myocardial Infarction (therapy)
• Biopsy
• Bone Marrow Examination
• Coronary Angiography
• Coronary Thrombosis (diagnosis, etiology)
• Drug Therapy, Combination
• Drug-Eluting Stents
• Humans
• Leukemia, Promyelocytic, Acute (complications, diagnosis)
• Male
• Middle Aged
• Platelet Aggregation Inhibitors (therapeutic use)
• Prosthesis Design
• Recurrence